Skip to main content
OpenTrials
Completed

NCT Number: NCT02152904

Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study

The purpose of the investigators study is to investigate the factors associated with rebleeding in patients with peptic ulcer bleeding.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Incheon St. Mary's Hospital

Incheon, South Korea

About this study

The investigators are performing a nationwide population based cohort study to investigate the factors associated with rebleeding in patients with peptic ulcer bleeding. The results of the investigators study should give us information about patients who are at high risk of rebleeindg and enable us to manage these patients appropriately.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with peptic ulcer bleeding by endoscopy
  • Patients who consent to be enrolled in the study

Exclusion criteria

  • Patients who refuse to be enrolled in the study

Treatment and study plan

Primary outcomes

  1. Rebleeding rate of peptic ulcer bleeding

    Time frame: 1 year

    The rebleeding rate of patients diagnosed with peptic ulcer ble4eding

Secondary outcomes

  1. Mortality rates of peptic ulcer bleeding

    Time frame: 30 days

    The 30 day mortality rate of patients diagnosed with peptic ulcer bleeding

Sponsors and collaborators

Lead sponsor

Joon Sung Kim

Other

Registry information

Acronym: KPUB

Important dates

Study start
2014
Primary completion
2015
Study completion
2016
First posted
Jun 2, 2014
Registry last updated
Aug 4, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.